Educational Activities Archives

Stimulant use, including cocaine, methamphetamine and prescription stimulants, continues to be a growing and urgent public health concern. According to the 2024 National Survey on Drug Use and Health, 9 million people in the U.S. had used stimulants not as prescribed in the past year. Though opioids are often the focus of overdose conversations, stimulant-related overdose deaths reached an estimated 51,630 in 2024, while 59% of all overdoses from January 2021 through June 2024 involved a stimulant (Centers for Disease Control and Prevention, 2025). These trends underscore the critical need for effective treatment and engagement strategies. Several evidence-based behavioral therapies exist to help providers treat stimulant use disorder. This webinar will outline the clinical and administrative approaches to assess, treat and support people experiencing stimulant use disorder.

This presentation synthesizes ethical frameworks, research evidence, and clinical examples to help practitioners make informed decisions about self-disclosure that prioritize client welfare, respect professional ethics, and optimize treatment outcomes.

Opioid use disorder (OUD) among women and people who become pregnant is increasing in prevalence in clinical settings. The standard of care is to provide buprenorphine or methadone as a part of a complete treatment approach during pregnancy and beyond the postpartum period. This module reviews the historical and current context of opioid use among women and birthing people during pregnancy. It compares pharmacological treatment options for women and people who become pregnant with an OUD and also discusses the issues with detoxification or medically assisted withdrawal from opioids during pregnancy. Issues related to the treatment of OUD during pregnancy and in the postpartum period for the birthing person, fetus and child will also be discussed (e.g., induction, dosing, pain management, neonatal withdrawal and how to reduce its severity).

This presentation explores how pharmacists and social workers can work together to expand access to medications for opioid use disorder by transforming interprofessional collaboration and creating hubs of care.

This webinar will examine how the court system impacts individuals with substance use disorders, explore the role of social workers in navigating this intersection, and highlight best practices for promoting recovery and justice.

Substance use disorders (SUDs) and incarceration are deeply intertwined, with many individuals entering the criminal justice system due to drug-related offenses or behaviors linked to addiction. This webinar explores the complex relationship between addiction and incarceration, examines systemic factors that perpetuate cycles of substance use and imprisonment, and considers the role of social workers in fostering change at both practice and policy levels.